about
Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the LiteratureThe virome in host health and diseaseRole of viruses and bacteria-virus interactions in autoimmunityThe Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human DiseaseEB virus reactivation triggers thrombotic thrombocytopenic purpura in a healthy adult.Gene Expression Profiles from Disease Discordant Twins Suggest Shared Antiviral Pathways and Viral Exposures among Multiple Systemic Autoimmune Diseases.Malignancies in systemic lupus erythematosus: a 2015 update.Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of Humoral Response to Common VirusesCancer and autoimmunity: Harnessing longitudinal cohorts to probe the link.Analysis of the cross-talk of Epstein-Barr virus-infected B cells with T cells in the marmoset.Targeting Epstein-Barr virus infection as an intervention against multiple sclerosis.Regulatory network analysis of Epstein-Barr virus identifies functional modules and hub genes involved in infectious mononucleosis.Human autoimmune diseases: a comprehensive update.Idiopathic nephrotic syndrome: the EBV hypothesis.Early life socioeconomic position and immune response to persistent infections among elderly LatinosHLA-DRB1 the notorious gene in the mosaic of autoimmunity.Chronic bacterial infection activates autoreactive B cells and induces isotype switching and autoantigen-driven mutations.Epstein-Barr virus in peripheral blood is associated with response to rituximab therapy in rheumatoid arthritis patients.Multiple Evanescent White Dot Syndrome following Acute Epstein-Barr Virus Infection.Dialogue: what can we learn about the relationship between systemic lupus erythematosus and haematological malignancies from linking disease registries?Infections and systemic lupus erythematosus.Identification of Epstein-Barr Virus in the Human Placenta and Its Pathologic Characteristics.Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to Rheumatoid Arthritis.Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity.Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections.Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.Epstein-Barr Virus DNA Enhances Diptericin Expression and Increases Hemocyte Numbers in Drosophila melanogaster via the Immune Deficiency Pathway.Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identificationEpstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9
P2860
Q26785523-7D0BD5E5-5BD4-47AB-8FD3-44D685735C2AQ26824795-EAF08FC4-5A2A-4148-80C8-ED19B20FE3B2Q26829755-768E7568-51EB-4339-90F0-A70C1FFB5045Q30278553-116A9678-CC39-437B-8AAC-098E2C1FF6DEQ30371742-2C7809CB-3014-49FB-A0C9-D31487010BD1Q31152067-622542D1-EFA2-4A24-A750-23394942399DQ33443601-067C6DC8-9752-40A6-B75C-5D856818C000Q35838076-DD633675-7643-4BA6-81EE-DC6819FFBC42Q36035448-81D120C5-7B92-439E-B435-A66952DCF304Q36339764-4E3D484F-E3B0-4989-9679-B63420CEF867Q37100264-988FD5C2-1445-4BE5-AB22-66BB01D31F67Q37644275-B03FF86E-2A73-4721-8128-90C5CD7354A5Q38248192-4FB6AF36-0E6C-4F30-8189-E7C57326C0BEQ38437452-07CEABD6-6345-4570-9617-FE02B941BB69Q38554722-62627194-289D-4388-AF75-AE1A2EB3A806Q38967341-FF72C1CE-2395-456C-807D-897124F70EADQ39471391-AF13AC51-6F67-41F6-9A5E-1B3522A2D115Q40607323-71EBCA6D-B2B7-41C0-9F49-40816EEAC296Q40948791-97DE6280-2122-4062-B272-23DE778A85C0Q41159831-F7BB00DA-657F-48B8-A227-6E9FFE5B59B4Q41918957-90BB9427-2E47-46CD-893F-A394ADE415B7Q41976089-293B9AED-9FA8-4369-9673-70BC68E5F204Q42220143-78558EEC-5BAC-4A10-9E70-D69EBDFB2033Q45325147-647B2164-7FD3-4E70-BE4C-EDE24B96B535Q47549698-0AF891CE-DFA6-424C-8B19-DA4978EA4702Q52319664-BA1A967E-DAAD-4A1A-92BF-05F4DAE40A1CQ52353641-54B8DE01-C991-40A8-9F92-AC6C9B9934ACQ53694309-B28310B8-2885-48CC-99B7-9B3E5A75BA80Q54263338-8CF49E1E-0977-440A-B660-FFFCD5C54194Q55269821-9FAB1F8C-EDB3-404C-981B-57FB0DB85417Q56888557-9B510D1D-0BC1-4B50-85DA-5078CA87CB10Q56891093-6C2B0A21-E0D1-4300-9FC4-A2A9C596E4A9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epstein-Barr virus in systemic autoimmune diseases
@en
Epstein-Barr virus in systemic autoimmune diseases.
@nl
type
label
Epstein-Barr virus in systemic autoimmune diseases
@en
Epstein-Barr virus in systemic autoimmune diseases.
@nl
prefLabel
Epstein-Barr virus in systemic autoimmune diseases
@en
Epstein-Barr virus in systemic autoimmune diseases.
@nl
P2860
P921
P356
P1476
Epstein-Barr virus in systemic autoimmune diseases
@en
P2093
Anette Holck Draborg
Karen Duus
P2860
P304
P356
10.1155/2013/535738
P50
P5008
P577
2013-08-24T00:00:00Z